| - GRCh37:
- Chr1:201009500
- GRCh38:
- Chr1:201040372
| CACNA1S | C1743* | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Pathogenic (Oct 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201009504
- GRCh38:
- Chr1:201040376
| CACNA1S | | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Likely pathogenic (Oct 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201009753
- GRCh38:
- Chr1:201040625
| CACNA1S | C1741* | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic (Dec 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201012490
- GRCh38:
- Chr1:201043362
| CACNA1S | L1656fs | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic (Dec 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201012510
- GRCh38:
- Chr1:201043382
| CACNA1S | D1650fs | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Pathogenic (Feb 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201012526
- GRCh38:
- Chr1:201043398
| CACNA1S | L1644* | Hypokalemic periodic paralysis | Likely pathogenic (Nov 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201012583-201012586
- GRCh38:
- Chr1:201043455-201043458
| CACNA1S | N1624fs | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic (Dec 17, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201012623
- GRCh38:
- Chr1:201043495
| CACNA1S | L1612fs | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic (Oct 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201012638
- GRCh38:
- Chr1:201043510
| CACNA1S | Q1607* | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Pathogenic (Jan 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201012661
- GRCh38:
- Chr1:201043533
| CACNA1S | | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, not provided, Hypokalemic periodic paralysis, type 1 | Likely pathogenic (Jun 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201013554-201013584
- GRCh38:
- Chr1:201044426-201044456
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic (Jun 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201016651
- GRCh38:
- Chr1:201047523
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, not provided
| Likely pathogenic (Aug 19, 2020) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201016756
- GRCh38:
- Chr1:201047628
| CACNA1S | | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Likely pathogenic (Dec 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201019548
- GRCh38:
- Chr1:201050420
| CACNA1S | A1404fs | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic (Aug 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201019585
- GRCh38:
- Chr1:201050457
| CACNA1S | W1391* | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic (May 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201019586
- GRCh38:
- Chr1:201050458
| CACNA1S | W1391* | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Pathogenic (Apr 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201020111
- GRCh38:
- Chr1:201050983
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
| Likely pathogenic (Sep 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201020111
- GRCh38:
- Chr1:201050983
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
| Likely pathogenic (Jul 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201020187
- GRCh38:
- Chr1:201051059
| CACNA1S | E1348fs | not provided | Likely pathogenic (Jun 19, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201020200
- GRCh38:
- Chr1:201051072
| CACNA1S | S1342* | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic (Oct 31, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201020237
- GRCh38:
- Chr1:201051109
| CACNA1S | L1330fs | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic (May 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201021683
- GRCh38:
- Chr1:201052555
| CACNA1S | | Malignant hyperthermia, susceptibility to, 5 | Likely pathogenic (Jun 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201022587
- GRCh38:
- Chr1:201053459
| CACNA1S | Q1265H | not provided, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
| Likely pathogenic (Oct 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201022609
- GRCh38:
- Chr1:201053481
| CACNA1S | W1258* | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic (Aug 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201022622
- GRCh38:
- Chr1:201053494
| CACNA1S | R1254* | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Pathogenic (Mar 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201022656
- GRCh38:
- Chr1:201053528
| CACNA1S | R1242S | Hypokalemic periodic paralysis, type 1 | Likely pathogenic (Apr 12, 2022) | no assertion criteria provided |
| - GRCh37:
- Chr1:201022657
- GRCh38:
- Chr1:201053529
| CACNA1S | R1242K | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic (Jun 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201022658
- GRCh38:
- Chr1:201053530
| CACNA1S | R1242G | Abnormality of the musculature | Pathogenic (Jul 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201022666
- GRCh38:
- Chr1:201053538
| CACNA1S | R1239H | Hypokalemic periodic paralysis, type 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, not provided | Pathogenic (Oct 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201022667
- GRCh38:
- Chr1:201053539
| CACNA1S | R1239C | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Likely pathogenic (Jul 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201022667
- GRCh38:
- Chr1:201053539
| CACNA1S | R1239G | not provided, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
| Pathogenic (Oct 4, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201022716
- GRCh38:
- Chr1:201053588
| CACNA1S | | Hypokalemic periodic paralysis, type 1 | Likely pathogenic (Nov 18, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201027621
- GRCh38:
- Chr1:201058493
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
| Pathogenic/Likely pathogenic (Jun 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201028316
- GRCh38:
- Chr1:201059188
| CACNA1S | | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Likely pathogenic (Jun 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201028369-201028370
- GRCh38:
- Chr1:201059241-201059242
| CACNA1S | T1158fs | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic (Jun 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201028428
- GRCh38:
- Chr1:201059300
| CACNA1S | | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Likely pathogenic (Oct 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201029865
- GRCh38:
- Chr1:201060737
| CACNA1S | W1112* | not provided | Likely pathogenic (May 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201029944
- GRCh38:
- Chr1:201060816
| CACNA1S | R1086S | not provided | Likely pathogenic (Sep 1, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201031099-201031100
- GRCh38:
- Chr1:201061971-201061972
| CACNA1S | T1009fs | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Pathogenic (Jul 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201031155
- GRCh38:
- Chr1:201062027
| CACNA1S | W990* | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201031621
- GRCh38:
- Chr1:201062493
| CACNA1S | D959fs | not provided | Likely pathogenic (Jul 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201031644
- GRCh38:
- Chr1:201062516
| CACNA1S | | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Likely pathogenic (Dec 16, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201034965
- GRCh38:
- Chr1:201065837
| CACNA1S | | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Likely pathogenic (Apr 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201035007
- GRCh38:
- Chr1:201065879
| CACNA1S | L938fs | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Pathogenic/Likely pathogenic (Aug 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201035395
- GRCh38:
- Chr1:201066267
| CACNA1S | R903* | not provided, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
| Pathogenic/Likely pathogenic (Jan 23, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201035402
- GRCh38:
- Chr1:201066274
| CACNA1S | R900S | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201035402
- GRCh38:
- Chr1:201066274
| CACNA1S | R900S | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Likely pathogenic (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201035411
- GRCh38:
- Chr1:201066283
| CACNA1S | R897S | not provided | Pathogenic (Feb 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201035412
- GRCh38:
- Chr1:201066284
| CACNA1S | R897K | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic (Jan 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201036045
- GRCh38:
- Chr1:201066917
| CACNA1S | V876E | Hypokalemic periodic paralysis, type 1 | Likely pathogenic (Oct 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201039430-201039436
- GRCh38:
- Chr1:201070302-201070308
| CACNA1S | E775fs | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Pathogenic (Nov 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201039467
- GRCh38:
- Chr1:201070339
| CACNA1S | Q765* | Hypokalemic periodic paralysis, type 1 | Likely pathogenic (Jul 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201039491
- GRCh38:
- Chr1:201070363
| CACNA1S | R757* | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic/Likely pathogenic (Feb 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201041886
- GRCh38:
- Chr1:201072758
| CACNA1S | P742S | not provided | Pathogenic (Apr 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201041954
- GRCh38:
- Chr1:201072826
| CACNA1S | | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Likely pathogenic (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201043633
- GRCh38:
- Chr1:201074505
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Likely pathogenic (Jul 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201044724
- GRCh38:
- Chr1:201075596
| CACNA1S | W616* | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic/Likely pathogenic (Feb 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201046079
- GRCh38:
- Chr1:201076951
| CACNA1S | N599fs | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Pathogenic (Apr 8, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201046141
- GRCh38:
- Chr1:201077013
| CACNA1S | M578I | Hypokalemic periodic paralysis, type 1 | Likely pathogenic (May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201047043
- GRCh38:
- Chr1:201077915
| CACNA1S | R528L | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, not provided
| Likely pathogenic (Oct 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201047043
- GRCh38:
- Chr1:201077915
| CACNA1S | R528H | not provided, Hypokalemic periodic paralysis, type 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic (Oct 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201047044
- GRCh38:
- Chr1:201077916
| CACNA1S | R528C | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, not provided
| Likely pathogenic (Feb 9, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201047044
- GRCh38:
- Chr1:201077916
| CACNA1S | R528G | Hypokalemic periodic paralysis, type 1 | Pathogenic (Apr 12, 2022) | no assertion criteria provided |
| - GRCh37:
- Chr1:201047123
- GRCh38:
- Chr1:201077995
| CACNA1S | C501* | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic (Mar 21, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201047212-201047225
- GRCh38:
- Chr1:201078084-201078097
| CACNA1S | N468fs | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1 | Pathogenic/Likely pathogenic (Feb 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201052317
- GRCh38:
- Chr1:201083189
| CACNA1S | Q456* | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic (Apr 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201052409
- GRCh38:
- Chr1:201083281
| CACNA1S | C425fs | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic (Mar 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201052414
- GRCh38:
- Chr1:201083286
| CACNA1S | W423* | not provided | Likely pathogenic (Aug 17, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201052430-201052431
- GRCh38:
- Chr1:201083302-201083303
| CACNA1S | N418fs | Malignant hyperthermia, susceptibility to, 5 | Pathogenic (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201052449
- GRCh38:
- Chr1:201083321
| CACNA1S | R412* | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1 | Pathogenic/Likely pathogenic (May 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201052451
- GRCh38:
- Chr1:201083323
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
| Likely pathogenic (Aug 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201054627
- GRCh38:
- Chr1:201085499
| CACNA1S | L363fs | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic (Jul 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201058386
- GRCh38:
- Chr1:201089258
| CACNA1S | W300* | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, not provided
| Pathogenic/Likely pathogenic (Sep 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201058389
- GRCh38:
- Chr1:201089261
| CACNA1S | Y299* | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Pathogenic (Aug 1, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201058492
- GRCh38:
- Chr1:201089364
| CACNA1S | W265* | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic (May 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201058554
- GRCh38:
- Chr1:201089426
| CACNA1S | C245fs | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic (Jun 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201058592
- GRCh38:
- Chr1:201089464
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Likely pathogenic (Jul 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201060898
- GRCh38:
- Chr1:201091770
| CACNA1S | I189fs | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic (Jul 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201061139
- GRCh38:
- Chr1:201092011
| CACNA1S | R168* | Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, not provided
| Pathogenic/Likely pathogenic (Sep 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:201061205
- GRCh38:
- Chr1:201092077
| CACNA1S | Q146fs | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Pathogenic (Mar 22, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201063084
- GRCh38:
- Chr1:201093956
| CACNA1S | Y108* | Abnormality of the musculature | Likely pathogenic (Jul 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201079290
- GRCh38:
- Chr1:201110162
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Likely pathogenic (Mar 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201079368
- GRCh38:
- Chr1:201110240
| CACNA1S | I61fs | Hypokalemic periodic paralysis, type 1 | Likely pathogenic (Nov 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201081383
- GRCh38:
- Chr1:201112255
| CACNA1S | R29fs | Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1 | Pathogenic (Jun 8, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201081390
- GRCh38:
- Chr1:201112262
| CACNA1S | R26fs | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic (Nov 15, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201081449
- GRCh38:
- Chr1:201112321
| CACNA1S | Q7* | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic (Jan 30, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:201012389-201013604
| CACNA1S | | Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5 | Pathogenic (Jul 19, 2022) | criteria provided, single submitter |
| | CACNA1S | | Myopathy, congenital, due to dihydropyridine receptor defect | Pathogenic (Mar 10, 2023) | no assertion criteria provided |
| | CACNA1S | | Myopathy, congenital, due to dihydropyridine receptor defect | Pathogenic (Mar 10, 2023) | no assertion criteria provided |
| | CACNA1S | | Myopathy, congenital, due to dihydropyridine receptor defect | Pathogenic (Mar 10, 2023) | no assertion criteria provided |
| | CACNA1S | | Myopathy, congenital, due to dihydropyridine receptor defect | Pathogenic (Mar 10, 2023) | no assertion criteria provided |
| | CACNA1S | | Myopathy, congenital, due to dihydropyridine receptor defect | Pathogenic (Mar 10, 2023) | no assertion criteria provided |
| | CACNA1S | | Myopathy, congenital, due to dihydropyridine receptor defect | Pathogenic (Mar 10, 2023) | no assertion criteria provided |
| | CACNA1S | | Myopathy, congenital, due to dihydropyridine receptor defect | Pathogenic (Mar 10, 2023) | no assertion criteria provided |
| | CACNA1S | | Myopathy, congenital, due to dihydropyridine receptor defect | Pathogenic (Mar 10, 2023) | no assertion criteria provided |
| | CACNA1S | | Myopathy, congenital, due to dihydropyridine receptor defect | Pathogenic (Mar 10, 2023) | no assertion criteria provided |
| | CACNA1S | | Myopathy, congenital, due to dihydropyridine receptor defect | Pathogenic (Mar 10, 2023) | no assertion criteria provided |